HomeComparePOLBF vs FCPT

POLBF vs FCPT: Dividend Comparison 2026

POLBF yields 3344.48% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 POLBF wins by $1284463355857.05M in total portfolio value
10 years
POLBF
POLBF
● Live price
3344.48%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1284463355857.10M
Annual income
$1,213,110,815,498,324,000.00
Full POLBF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — POLBF vs FCPT

📍 POLBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPOLBFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, POLBF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
POLBF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

POLBF
Annual income on $10K today (after 15% tax)
$284,280.94/yr
After 10yr DRIP, annual income (after tax)
$1,031,144,193,173,575,300.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, POLBF beats the other by $1,031,144,193,173,570,400.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of POLBF + FCPT for your $10,000?

POLBF: 50%FCPT: 50%
100% FCPT50/50100% POLBF
Portfolio after 10yr
$642231677928.58M
Annual income
$606,555,407,749,164,900.00/yr
Blended yield
94.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

POLBF
No analyst data
Altman Z
39.8
Piotroski
1/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

POLBF buys
0
FCPT buys
0
No recent congressional trades found for POLBF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPOLBFFCPT
Forward yield3344.48%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1284463355857.10M$49.1K
Annual income after 10y$1,213,110,815,498,324,000.00$5,775.28
Total dividends collected$1279557275592.29M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: POLBF vs FCPT ($10,000, DRIP)

YearPOLBF PortfolioPOLBF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$345,148$334,448.16$11,401$700.92+$333.7KPOLBF
2$11,157,548$10,788,239.94$13,064$864.84+$11.14MPOLBF
3$337,872,856$325,934,279.31$15,051$1,072.48+$337.86MPOLBF
4$9,585,767,941$9,224,243,985.35$17,442$1,337.22+$9585.75MPOLBF
5$254,836,586,625$244,579,814,927.95$20,340$1,677.08+$254836.57MPOLBF
6$6,349,429,806,239$6,076,754,658,549.98$23,880$2,116.57+$6349429.78MPOLBF
7$148,295,333,941,378$141,501,444,048,701.88$28,241$2,689.36+$148295333.91MPOLBF
8$3,247,334,232,557,481$3,088,658,225,240,206.50$33,660$3,442.07+$3247334232.52MPOLBF
9$66,684,617,157,738,690$63,209,969,528,902,180.00$40,456$4,439.95+$66684617157.70MPOLBF
10$1,284,463,355,857,104,100$1,213,110,815,498,324,000.00$49,063$5,775.28+$1284463355857.05MPOLBF

POLBF vs FCPT: Complete Analysis 2026

POLBFStock

Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class intranasally administered RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro­ and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

Full POLBF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this POLBF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

POLBF vs SCHDPOLBF vs JEPIPOLBF vs OPOLBF vs KOPOLBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.